SERA PROGNOSTICS, INC. (SERA) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US81749D1072
SERA PROGNOSTICS, INC. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 81,000.00 USD |
| Gross profit | -83,000.00 USD |
| Operating income | -36.50 m USD |
| EBIT | -31.92 m USD |
| Net income | -31.93 m USD |
| Diluted EPS – continuing operations | -0.67 USD |
Full history since 2019, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About SERA PROGNOSTICS, INC.
Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests, and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation. It is also involved in the development of a pipeline of novel blood-based biomarker tests and predictive analytic products and services for pregnancy related conditions, such as time-to-birth, predictive analytics product, pregnancy risk prediction panel, preeclampsia, and fetal growth restriction. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.
More stocks
- KTI (0308.KL)
- Kyungdong City Gas Co Ltd (267290.KS)
- Kyungin Synthe (012610.KS)
- Jaeyoung Solutec Co. Ltd (049630.KQ)
- Great Novel Therapeutics Biotech & Medicals (7427.TWO)
- Yen Sun Technology (6275.TWO)
- Iljin Diamond (081000.KS)
- Adocia (ADOC.PA)
- Doosan Solus Co Ltd Pref 1P (33637K.KS)
- Premier Technology Public Company Limited (PT.BK)
- Kworld Computer Co Ltd (3287.TWO)
- Nang Kuang Pharmaceutical Co Ltd (1752.TW)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.